The company announced the findings from the new Phase 3 trial, which included more than 32,000 participants and may boost confidence in the vaccine

The findings from the new Phase 3 trial, which included more than 32,000 participants, may boost confidence in the vaccine, which was originally developed by the University of Oxford. The … Read More

Loading

Follow by Email
Pinterest
LinkedIn
Share